News
Dianthus Therapeutics targets severe autoimmune diseases with DNTH103. Read more on DNTH's promise amid competitive ...
MMN2018: 8th Mismatch Negativity conference “MMN from basic science to clinical applications” The 8th Mismatch Negativity conference “MMN from basic science to clinical applications”, celebrating 40th ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback